Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases
Beatriz Martínez–Delgado(Centre for Biomedical Network Research on Rare Diseases), Javier Benı́tez(Spanish National Cancer Research Centre), Honglin Song(University of Cambridge), Ana Blanco(Fundación Pública Galega de Medicina Xenómica), Trinidad Caldés(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Rogelio González‐Sarmiento(Universidad de Salamanca), Ana Vega(Complejo Hospitalario Universitario de Santiago), Miguel de la Hoya, Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Lucía Inglada‐Pérez(Spanish National Cancer Research Centre), Marı́a A. Blasco(Spanish National Cancer Research Centre), Miguel Urioste(Instituto de Salud Carlos III), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Kira Yanowsky(Spanish National Cancer Research Centre)
Cited by 54
Related Papers
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k
Association analysis identifies 65 new breast cancer risk loci
|Nature|2017|1.6k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k